Stay updated on Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check23 days agoChange DetectedA sitewide NIH notice announces updates to terminology during the transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.5%

- Check30 days agoChange DetectedThe website footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history shows a new latest entry: Revision: v3.7.0 has been added, replacing v3.6.6. This indicates a system update to the study record history page rather than a change to the study information.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now reflects a new revision entry for v3.6.6, replacing the prior v3.6.5 entry; this indicates an update to the record's documentation rather than substantive study information.SummaryDifference0.1%

Stay in the know with updates to Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.